TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model

BACKGROUND: Rapid development of antibiotic resistance necessitates advancement of novel therapeutic strategies to treat infection. Mesenchymal stromal cells (MSC) possess antimicrobial and immunomodulatory properties, mediated through antimicrobial peptide secretion and recruitment of innate immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Pezzanite, Lynn M., Chow, Lyndah, Phillips, Jennifer, Griffenhagen, Gregg M., Moore, A. Russell, Schaer, Thomas P., Engiles, Julie B., Werpy, Natasha, Gilbertie, Jessica, Schnabel, Lauren V., Antczak, Doug, Miller, Donald, Dow, Steven, Goodrich, Laurie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708491/
https://www.ncbi.nlm.nih.gov/pubmed/36467344
http://dx.doi.org/10.21037/atm-22-1746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708491/
https://www.ncbi.nlm.nih.gov/pubmed/36467344
http://dx.doi.org/10.21037/atm-22-1746

Ejemplares similares